Patent details
EP2117584 Title: USE OF BOTULINUM TOXIN AND ENZYMES FOR TREATING BLADDER DISORDERS
Basic Information
- Publication number:
- EP2117584
- PCT Application Number:
- PCT/US/2008/053989
- Type:
- European Patent Granted for LU
- Legal Status:
- Lapsed
- Application number:
- EP087434767
- PCT Publication Number:
- WO/2008/101098
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- USE OF BOTULINUM TOXIN AND ENZYMES FOR TREATING BLADDER DISORDERS
- French Title of Invention:
- UTILISATION DE TOXINE BOTULIQUE ET D'ENZYMES POUR TRAITER DES DÉSORDRES DE LA VESSIE
- German Title of Invention:
- VERWENDUNG VON BOTULINUMTOXIN UND ENZYMEN ZUR BEHANDLUNG VON BLASENLEIDEN
- SPC Number:
Dates
- Filing date:
- 14/02/2008
- Grant date:
- 09/10/2013
- EP Publication Date:
- 09/10/2013
- PCT Publication Date:
- 21/08/2008
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 18/11/2009
- EP B1 Publication Date:
- 09/10/2013
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- 14/02/2014
- Expiration date:
- 14/02/2028
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 14/02/2008
- Name:
- ALLERGAN INC.
- Address:
- 2525 Dupont Drive, Irvine CA 92612, United States (US)
- Name:
- Gaylis Franklin David
- Address:
- 8851 Center Drive Suite 501, La Mesa CA 91942, United States (US)
Inventor
1
- Name:
- GAYLIS Franklin, David
- Address:
- United States (US)
2
- Name:
- BLUMENFELD Andrew, M.
- Address:
- United States (US)
Priority
- Priority Number:
- 890052 P
- Priority Date:
- 15/02/2007
- Priority Country:
- United States (US)
Classification
- Main IPC Class:
- A61K 38/43;
| Filing date | Document type | Number of pages |
|---|